
|Articles|April 1, 2001
New drug for Alzheimer's
News brief.
Advertisement
Research Headlines
New drug for Alzheimer's
By Jeanne Sabatie, Production Editor
Reminyl has been approved by the FDA for the treatment of mild to moderate Alzheimer's disease. Clinical trials show that the drug, derived from the bulbs of daffodils, can improve patients' daily function and ability to think. The Rx drug is scheduled to be available in May.
Jeanne Sabatie. New drug for Alzheimer's.
Business and Health
2001;4:10.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Transplant-fueled hybrid immune systems may help reverse Type 1 diabetes
2
ACIP to vote on major hepatitis B vaccine update that could reshape the childhood vaccine schedule
3
ACIP votes to end universal birth-dose for hepatitis B vaccine with updated guidance for parents and doctors
4
New test may solve the specificity and false-positive problems of the PSA test for prostate cancer
5





















































